AZoRobotics | IN-TIME Study Shows Significant Reduction in All-Cause Mortality in ICD and ... Marketwire (press release) The BIOTRONIK sponsored IN-TIME study is the first randomized, controlled trial worldwide that demonstrated a significant reduction in all-cause mortality in heart failure patients with implant-based remote monitoring. In patients with severely ... IN-TIME sees better results, fewer deaths, with HF home monitoring |
